⦿ Executive Snapshot

• What: FINRA is set to review firm practices regarding higher-risk structured products, particularly non-principal protected "worst-of" structured notes.
• Who: Financial Industry Regulatory Authority (FINRA) and member firms involved in structured product recommendations.
• Why it matters: The review aims to enhance investor protection and ensure compliance with Regulation Best Interest amid rising complexities and risks associated with these financial instruments.

⦿ Key Developments

• FINRA will examine how firms supervise concentrations in higher-risk structured products and their compliance with existing regulations.
• The review focuses on structured notes that are linked to the performance of the worst performing asset in a group, which have unique risks and complexities.
• There have been multiple instances where firm representatives concentrated clients' assets in these structured products, increasing investment risk.

⦿ Strategic Context

• Structured products are designed to meet specific investment objectives, combining traditional securities with derivative components, but they carry inherent risks due to their complexity.
• The scrutiny comes amid concerns that concentrated investments in complex products can lead to significant losses, particularly when not aligned with overall market conditions.

⦿ Strategic Implications

• Immediate implications include enhanced scrutiny on how firms train and supervise representatives who recommend these products, potentially leading to stricter compliance requirements.
• In the long-term, this may result in a reevaluation of how structured products are marketed and sold to retail investors, impacting their availability and the nature of advice given.

⦿ Risks & Constraints

• Potential regulatory roadblocks may arise as firms adapt to increased scrutiny and compliance requirements from FINRA's review.
• The complexity of structured products may deter some firms from offering them, limiting investor access to potentially beneficial investment strategies.

⦿ Watchlist / Forward Signals

• Firms are encouraged to evaluate their training, guidance, controls, and supervisory structures in relation to structured product recommendations.
• Future developments will depend on the outcomes of FINRA's review and any subsequent regulatory changes that may emerge from its findings.